GREG COLLIER, PhD
Chief Executive Officer and Managing Director

Dr. Collier has more than 20 years experience spanning commercial, operational, clinical and scientific aspects of pharmaceutical research and development, and is a regular invited speaker at international research and biotechnology conferences. Under Dr. Collier’s guidance ChemGenex has aggressively focussed on the company’s progression to the clinic and eventual marketing approval of lead agents. Dr. Collier has a detailed understanding of both the developmental and managerial drivers of value in the biotech industry, and has overseen an international merger, a listing on NASDAQ and several substantial capital raisings. Dr. Collier has a PhD in biochemistry from Monash University and is the co-inventor of 33 patents and co-author of more than 120 scientific publications.